W.W. Grainger, Inc. - 10-Q Summary (Period Ended Sept 30, 2007)
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for W.W. Grainger, Inc., a leading broad-line supplier of facilities maintenance products and services in North America. The report covers the three and nine months ended September 30, 2007. The Company operates through three segments: Grainger Branch-based, Acklands-Grainger Branch-based (Canada), and Lab Safety Supply, Inc.
Key Financial Metrics
| Metric | 3 Months Ended Sept 30, 2007 | 9 Months Ended Sept 30, 2007 |
|---|---|---|
| Net Sales | $1,658.6 million | $4,806.3 million |
| Gross Profit | $659.6 million (39.8% margin) | $1,932.1 million (40.2% margin) |
| Operating Earnings | $174.3 million (10.5% margin) | $503.5 million (10.5% margin) |
| Net Earnings | $109.2 million | $315.7 million |
| Diluted EPS | $1.29 | $3.67 |
| Cash from Operations (9mo) | $337.8 million | |
| Short-Term Debt | $144.2 million (as of Sept 30, 2007) | |
| Long-Term Debt | $4.9 million (as of Sept 30, 2007) | |
| Cash & Equivalents | $89.4 million (as of Sept 30, 2007) |
Material Changes vs. Prior Period
- Sales Growth: Net sales increased 9.2% in Q3 and 8.7% for the nine-month period compared to 2006. Growth was driven by market expansion and product line expansion initiatives, partially offset by the wind-down of low-margin integrated supply contracts.
- Profitability: Operating earnings rose 15.2% in Q3 and 17.0% for the nine months. Gross profit margins improved due to positive inflation recovery.
- Earnings Per Share: Diluted EPS increased 11.2% in Q3 and 18.0% for the nine months. This outpaced net earnings growth due to significant share repurchases.
- Liquidity: Cash and cash equivalents decreased significantly from $348.5 million (Dec 31, 2006) to $89.4 million (Sept 30, 2007), primarily due to a $500 million accelerated share repurchase (ASR) program and treasury stock purchases totaling $647.3 million in the first nine months.
- Debt: Short-term debt increased to $144.2 million, largely to fund the ASR program. Total debt as a percent of total capitalization rose to 7.2% from 0.4% at year-end 2006.
Guidance, Outlook, and Risks
- Share Repurchases: The Company entered a $500 million ASR agreement in August 2007. Management estimates a benefit of $0.01 per share for the remainder of 2007. Approximately 4.7 million shares remain available under the repurchase authorization.
- Cost Reductions: Management identified up to 125 IT positions for elimination in Q4 2007, anticipating a charge of up to $6 million and cost reductions of up to $12 million in 2008.
- Expansion: The U.S. market expansion program is expected to be completed in 2008. Phase 6 (Chicago, Minneapolis, Pittsburgh, San Francisco) is currently underway.
- Tax Matters: The 2006 comparative periods included an $8.5 million benefit from a 2004 tax audit settlement, which is not present in 2007. The effective tax rate for the nine months ended Sept 30, 2007, was 38.5%.
- Risks: Forward-looking statements are subject to risks including higher product costs, competitive pricing pressure, economic conditions (industrial production, employment levels), and currency fluctuations.
Investor Verification Checklist
- Share Count Impact: Verify the final share count adjustment from the $500 million ASR agreement, which concludes in April 2008.
- Q4 Charges: Monitor the fourth quarter for the anticipated $6 million charge related to IT workforce reductions.
- Margin Sustainability: Assess whether gross margin improvements from inflation recovery can be sustained against potential cost increases or mix shifts.
- Cash Position: Review the impact of the reduced cash balance ($89.4 million) on liquidity and working capital flexibility, noting the reliance on commercial paper.
- Segment Performance: Confirm continued growth in the Mexico operations (up 24.3% in Q3) and the performance of the Lab Safety segment post-acquisition.